KRN5500

DRUG3 trials

Sponsors

Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI), DARA Therapeutics

Conditions

Neuropathic PainUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

KRN5500 in Treating Patients With Solid Tumors

CompletedNCT00017238

National Cancer Institute (NCI)Unspecified Adult Solid Tumor, Protocol Specific

Start: 2002-02-28Updated: 2013-01-11

KRN5500 in Treating Patients With Metastatic Solid Tumors

CompletedNCT00002923

Barbara Ann Karmanos Cancer InstituteUnspecified Adult Solid Tumor, Protocol Specific

Start: 1997-05-31End: 2000-10-31Target: 27Updated: 2014-04-25

Phase 2

Neuropathic Pain in Patients With Cancer

CompletedNCT00474916

DARA TherapeuticsNeuropathic Pain

Start: 2006-06-30End: 2009-04-30Updated: 2010-08-16